Terms: = Cervical cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
81 results:
1. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
2. Tumor and metastatic lymph nodes metabolic activity on
Song J; Pang W; Yi H; Ji J; Ye X; Li L
Abdom Radiol (NY); 2024 Mar; 49(3):975-984. PubMed ID: 38302763
[TBL] [Abstract] [Full Text] [Related]
3. Knowledge and Perceptions of cervical cancer Screening in Nhlambeni, Eswatini: Understanding Facilitators and Barriers for Prevention Interventions.
Maseko T; Tsoka-Gwegweni JM; Ndirangu J; Okello V; Dlamini X
West Afr J Med; 2023 Dec; 40(12):1325-1331. PubMed ID: 38261526
[TBL] [Abstract] [Full Text] [Related]
4. Differentiation of cancer of unknown primary and lymphoma in head and neck metastatic poorly differentiated cancer using 18 F-FDG PET/CT tumor metabolic heterogeneity index.
Xu M; Gu B; Zhang J; Xu X; Qiao Y; Hu S; Song S
Nucl Med Commun; 2024 Feb; 45(2):148-154. PubMed ID: 38095143
[TBL] [Abstract] [Full Text] [Related]
5. MRI-based radiomic signatures for pretreatment prognostication in cervical cancer.
Wagner-Larsen KS; Hodneland E; Fasmer KE; Lura N; Woie K; Bertelsen BI; Salvesen Ø; Halle MK; Smit N; Krakstad C; Haldorsen IS
Cancer Med; 2023 Oct; 12(20):20251-20265. PubMed ID: 37840437
[TBL] [Abstract] [Full Text] [Related]
6. Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.
Passey C; Voellinger J; Gibiansky L; Gunawan R; Nicacio L; Soumaoro I; Hanley WD; Winter H; Gupta M
CPT Pharmacometrics Syst Pharmacol; 2023 Sep; 12(9):1262-1273. PubMed ID: 37496366
[TBL] [Abstract] [Full Text] [Related]
7. Value of [
Burchardt E; Bos-Liedke A; Serkowska K; Cegla P; Piotrowski A; Malicki J
Sci Rep; 2023 Jun; 13(1):9092. PubMed ID: 37277546
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix.
Chen J; Ma N; Sun M; Chen L; Yao Q; Chen X; Lin C; Lu Y; Lin Y; Lin L; Fan X; Chen Y; Wu J; He H
PeerJ; 2023; 11():e15084. PubMed ID: 37020850
[TBL] [Abstract] [Full Text] [Related]
9. Dosimetric analysis of intensity-modulated radiation therapy and volumetric-modulated arc therapy in comparison with conventional box technique in the treatment of carcinoma cervix: An impact of prosthetic implant.
Bhushan M; Tripathi D; Yadav G; Kumar L; Chowdhary RL; Pahuja AK; Suhail M; Mitra S; Gairola M
J Cancer Res Ther; 2022; 18(6):1504-1512. PubMed ID: 36412401
[TBL] [Abstract] [Full Text] [Related]
10. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract] [Full Text] [Related]
11. Toward 3D-TRUS image-guided interstitial brachytherapy for cervical cancer.
Knoth J; Nesvacil N; Sturdza A; Kronreif G; Widder J; Kirisits C; Schmid MP
Brachytherapy; 2022; 21(2):186-192. PubMed ID: 34876361
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological Analysis of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review of 9 Cases.
Sağnıç S; Birge Ö; Bakır MS; Karadag C; Şimşek T
Int J Surg Oncol; 2021; 2021():8290659. PubMed ID: 34567803
[TBL] [Abstract] [Full Text] [Related]
13. Whole-tumor histogram analysis of apparent diffusion coefficient for differentiating adenosquamous carcinoma and adenocarcinoma from squamous cell carcinoma in patients with cervical cancer.
Xiao M; Ma X; Ma F; Li Y; Zhang G; Qiang J
Acta Radiol; 2022 Oct; 63(10):1415-1424. PubMed ID: 34382429
[TBL] [Abstract] [Full Text] [Related]
14. Dosimetric study of a hybrid plan technique for external beam radiotherapy in patients with cervical cancer.
Martín-Tovar EA; Badillo-Alvarado AH; Cocom-Poot LE
Radiat Environ Biophys; 2021 Nov; 60(4):653-662. PubMed ID: 34363120
[TBL] [Abstract] [Full Text] [Related]
15. Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [
Linz C; Brands RC; Kertels O; Dierks A; Brumberg J; Gerhard-Hartmann E; Hartmann S; Schirbel A; Serfling S; Zhi Y; Buck AK; Kübler A; Hohm J; Lapa C; Kircher M
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3951-3960. PubMed ID: 34050405
[TBL] [Abstract] [Full Text] [Related]
16. Standardized Uptake Value Illuminates Tumor Inflammation and treatment Response.
Williamson CW; Zamarin D; Mayadev J
Clin Cancer Res; 2021 Aug; 27(15):4136-4138. PubMed ID: 34016640
[TBL] [Abstract] [Full Text] [Related]
17. Dosimetric analysis of cervical cancer stage IIB patients treated with volumetric modulated arc therapy using plan uncertainty parameters module of Varian Eclipse treatment planning system.
Singh G; Tyagi A; Thaper D; Kamal R; Kumar V; Oinam AS; Srivastava R; Halder S; Hukku S
Biomed Phys Eng Express; 2021 Apr; 7(3):. PubMed ID: 33862601
[No Abstract] [Full Text] [Related]
18. PET/MR imaging for the evaluation of cervical cancer during pregnancy.
Ishiguro T; Nishikawa N; Ishii S; Yoshihara K; Haino K; Yamaguchi M; Adachi S; Watanabe T; Soeda S; Enomoto T
BMC Pregnancy Childbirth; 2021 Apr; 21(1):288. PubMed ID: 33838651
[TBL] [Abstract] [Full Text] [Related]
19. Endoscopic and clinical correlation with dose to sigmoid colon in carcinoma cervix patients treated with radical radiotherapy.
Elagandula J; Arulponni TR
J Cancer Res Ther; 2021; 17(1):174-179. PubMed ID: 33723151
[TBL] [Abstract] [Full Text] [Related]
20. The clinical impact of removing rectal gas on high-dose-rate brachytherapy dose distributions for gynecologic cancers.
Vergalasova I; Ennis RD; Sayan M; Liu B; Yue NJ; Hathout L
J Appl Clin Med Phys; 2021 Feb; 22(2):35-41. PubMed ID: 33440079
[TBL] [Abstract] [Full Text] [Related]
[Next]
